Medical Director, AMyC
Co-Chair Myeloma Committee, SWOG
Chairman, International Myeloma Foundation
Specialist in Multiple Myeloma and Related Disorders
Cedars-Sinai Outpatient Cancer Center
Los Angeles, California
Professor of Clinical Hematology
Head, Hematology Department
University Hospital Hôtel-Dieu
Department of Hematology and Immunology
Flow Cytometry Core - CIMA LAB Diagnostics
University of Navarra
Edward W. and Betty Knight Scripps Professor of Medicine
Director of Clinical and Translational Medicine
Universidad de Navarra
Associate Scientific Director
Senior Clinical Editor
Editorial Director, Hematology/Oncology
Senior Scientific Director
This program is intended for physicians and other healthcare providers who care for patients with multiple myeloma.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 2.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 30, 2018, through April 29, 2019:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
Ian W. Flinn, MD, PhD, answers frequently asked questions on use of BTK inhibitors in patients with hematologic malignancies in this CCO commentary
Commentary on pharmacist’s role in preventing, identifying, and caring for patients experiencing CAR T-cell–associated acute and long-term toxicities.
CME-certified interactive virtual presentation from Clinical Care Options (CCO) with case-based expert insights on using targeted therapies for treating patients with CLL
Downloadable slides on the most recent clinical data on targeted therapies in CLL from Clinical Care Options (CCO).
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.